Security record · archived quarter
IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
6Tracked holders
—Δ holders
4.42MShares held
$27.95MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +5 | 153.88M | $1.35B | +10 | −5 |
| Q1 2026 | 103 | +11 | 130.83M | $998.92M | +19 | −8 |
| Q4 2025 | 91 | -1 | 143.54M | $283.94M | — | −1 |
| Q3 2025 | 15 | 0 | 77.60M | $190.89M | +2 | −2 |
| Q2 2025 | 12 | +1 | 58.35M | $154.05M | +1 | — |
| Q1 2025 | 8 | 0 | 12.96M | $39.01M | +1 | −1 |
| Q4 2024 | 8 | +1 | 14.27M | $36.54M | +2 | −1 |
| Q3 2024 | 6 | 0 | 5.93M | $22.06M | +1 | −1 |
| Q2 2024 | 6 | — | 4.42M | $27.95M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.92M | — | $24.76M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.92M | — | $24.76M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 216.98K | — | $1.37M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 130.76K | — | $828,000 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 130.76K | — | $828,000 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 93.59K | — | $591,495 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 48.45K | — | $306,216 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 48.45K | — | $306,216 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 14.59K | — | $92,234 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 383 holders, 176.43M shares, $1.31B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API